Sichenzia Ross Ference LLP Represents SeaChange International, Inc. in $19.1 Million Public Offering of Common Stock

Press Release – New York, NY – April 5, 2021 – Sichenzia Ross Ference LLP today announced that it represented SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, in a public offering of 10,323,484 shares of the company’s common stock.  The offering was priced at $1.85 per share, which was above the five-day average closing price of $1.26. The gross proceeds were approximately $19.1 million. Additionally, the Company has granted the underwriter an option to purchase an additional 15 percent of the common stock offered in the public offering solely to cover over-allotments, if any, exercisable for 45 days after the closing of this offering, which if exercised, would bring total gross proceeds to approximately $22.0 million. 

Aegis Capital Corp. acted as sole bookrunner for the offering.

The offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-252777) previously filed with the U.S. Securities and Exchange Commission and declared effective on March 16, 2021. 

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Avital Perlman, Jeffrey Cahlon, associate Terra Melson and law clerk Zachary Weiss.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

SRFC is a full-service law firm with nationally recognized corporate, securities, and litigation practices that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• 美国思成律师事务所代表健永生技(Jyong Biotech)完成在纳斯达克交易所2000万美元的首次公开发行 - June 17, 2025
• Sichenzia Ross Ference Carmel LLP Represents Jyong Biotech in $20 Million Initial Public Offering - June 17, 2025
• Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $100 Million Private Offering of SRM Entertainment to Launch TRON Crypto Treasury Strategy - June 16, 2025